{
    "2021-10-18": [
        [
            {
                "time": "2023-10-16",
                "orginal_text": "医药生物行业周报：疫苗加强针接种工作陆续开启 关注三季报业绩预期差投资机会",
                "features": {
                    "keywords": [
                        "疫苗",
                        "加强针",
                        "三季报",
                        "业绩预期差",
                        "投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "orginal_text": "北向资金净卖出额创近2个月新高，贵州茅台遭大幅抛售逾14亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净卖出",
                        "贵州茅台",
                        "抛售"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-16",
                "orginal_text": "医药生物行业周报：季度业绩波动该如何应对",
                "features": {
                    "keywords": [
                        "医药生物",
                        "季度业绩",
                        "波动"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "orginal_text": "匆匆终止 百克生物新冠疫苗项目“画大饼”",
                "features": {
                    "keywords": [
                        "百克生物",
                        "新冠疫苗",
                        "项目终止"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-16",
                "orginal_text": "融资客青睐7股，万事利买入占比高达48.60%",
                "features": {
                    "keywords": [
                        "融资客",
                        "万事利",
                        "买入占比"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "其他"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "orginal_text": "医药生物行业：创新药国谈价格前瞻分析",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新药",
                        "国谈价格",
                        "前瞻分析"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}